Covid update

BioConnection ensures your clinical and commercial supply line for steriles, even in pandemic times

Have you experienced the worldwide GMP manufacturing capacity for sterile injectables being very limited due to the high demand for Covid-19 treatments and vaccines? Do you worry that this will jeopardize the timelines of your Drug Product program?

As of April this year we have increased our GMP Fill & Finish manufacturing capacity, enabling the aseptic production of up to 40 million vials per year for liquid products and up to 4 million vials per year for freeze dried products. We operate in an EMA and US-FDA certified facility and have four different production lines covering batch sizes ranging from 0.1L up till 1,000L/batch. Whether it is a liquid or a lyophilized Drug Product, at clinical or at larger commercial scale we can support you despite the challenging Covid-19 pandemic times.

Moreover we offer a vast array of additional services beyond the Drug Product manufacture such as (but not limited to): QP release to clinic or market, release analytics, labeling & packaging, stability studies, formulation and lyo-cycle development to name a few, which will help to bring your product fast(er) to the clinic or to the market.

We fully understand that timing is crucial and we are used to acting fast and focused enabling lead times from the first client contact up to production of a first GMP Drug Product batch to be as short as four months. Don’t wait any longer – contact us to discuss your needs and discover how can we be of service.

We are ready to support your Fill & Finish programs!

Our four different production lines

Automated vial line
(class A, aseptic)
Up to 50L + 3m² freeze dryer
for standard vial formats
Automated vial line
(class A, aseptic)
Up to 1,000L + 10m² freeze dryer
for standard vial formats
Manual fill unit
(class A, aseptic)
Around 1,000 units/ batch
for standard vial formats + bags + bottles, etc.
Syringe filling line
(class A, aseptic)
Up to 50L
5,000 syringes/ hour

Contact Marco Jaspers for clinical supply queries and Sjaak Stevense or Dennis Link for commercial supply queries. Let’s discuss today how can we be at your service tomorrow.

We look forward supporting you with our Fill & Finish services.

bioconnection

Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM (www.rivm.nl). This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project (expansion.bioconnection.eu) is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via contact@bioconnection.eu.

The BioConnection Management Team.

You have Successfully Subscribed!